HIMS (Hims & Hers Health) Other Long-Term Liabilities: $90 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HIMS Hims & Hers Health Inc HIMS
78 GF Score
Price $28.15
GF Value $42.24
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Hims & Hers Health Other Long-Term Liabilities?

Hims & Hers Health HIMS -2.16% 78 Other Long-Term Liabilities is $90 Mil as of Jun. 2026. GuruFocus rates HIMS with a GF Score™ of 78/100 and a GF Value™ of $42.24 (Possible Value Trap). The stock has 4 warning signs investors should review.

Hims & Hers Health's other long-term liabilities for the quarter that ended in Jun. 2026 was $90 Mil.

Hims & Hers Health's quarterly other long-term liabilities declined from Dec. 2025 ($65 Mil) to Mar. 2026 ($25 Mil) but then increased from Mar. 2026 ($25 Mil) to Jun. 2026 ($90 Mil).

Hims & Hers Health's annual other long-term liabilities declined from Dec. 2023 ($0 Mil) to Dec. 2024 ($0 Mil) but then increased from Dec. 2024 ($0 Mil) to Dec. 2025 ($65 Mil).

Hims & Hers Health Other Long-Term Liabilities Related Terms

Hims & Hers Health Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Other Long-Term Liabilities Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial 2.63 3.01 0.02 0.00 64.74

Hims & Hers Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 55.73 64.74 25.19 90.26
HIMS
78GF Score
Hims & Hers Health Inc HIMS
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $90 Mil mean?
Hims & Hers Health (HIMS) has a Other Long-Term Liabilities of $90 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Other Long-Term Liabilities too high?
Hims & Hers Health's current Other Long-Term Liabilities is $90 Mil. Overall, Hims & Hers Health has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Other Long-Term Liabilities compare to LNTH and AMRX?
Hims & Hers Health's Other Long-Term Liabilities of $90 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Drug Manufacturers company?
A good Other Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Other Long-Term Liabilities is $90 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Based on GuruFocus' analysis, Hims & Hers Health (HIMS) is currently considered Possible Value Trap. The stock's GF Value™ is $42.24, compared to a current price of $28.15 — trading 33.4% below its estimated fair value. The current Other Long-Term Liabilities is $90 Mil. Hims & Hers Health's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Hims & Hers Health (HIMS), the current Other Long-Term Liabilities is $90 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of $28.15 is trading 33.4% below its estimated GF Value™ of $42.24. GuruFocus considers Hims & Hers Health to be Possible Value Trap.

Key valuation signals for HIMS:

  • Other Long-Term Liabilities: $90 Mil
  • GF Value™: $42.24 vs. price of $28.15 (33.4% below fair value)
  • GF Score™: 78/100 with 4 warning signs

No single metric tells the full story. See the HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Other Exchanges HIMS:Mexico82W:Germany
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
78GF Score

Get the complete analysis for HIMS

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.15
Price
$42.24
GF Value